CD7 and cancer: A major difficulty of the development of CAR-T cells against T cell driven cancers is that the attractive antigens (such as CD7) are expressed on normal T cell surfaces as well, leading to potential fratricide of CAR-T cells (i.e., CAR-T cells attack each other due to the presence of CD7).